Identification of arthritogenic adjuvants of self and foreign origin

Scandinavian Journal of Immunology

Volumn 49, Issue 1, 1999, Pages 45-50

  Lorentzen, Johnny C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; CORD FACTOR; HYDROCARBON; IMMUNOLOGICAL ADJUVANT; LIPOPOLYSACCHARIDE; SQUALENE;

ADJUVANT ARTHRITIS; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CELL WALL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; STRAIN DIFFERENCE;

EID: 0032952871     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00463.x     Document Type: Article

References (34)

1. 1 Kleinau S, Erlandsson H, Holmdahl R, Klareskog L. Adjuvant oils induce arthritis in the DA rat. I. Characterisation of the disease and evidence for an immunological involvement. J Autoimmunity 1991;4:871-80.
2. 2 Deighton CM, Walker DJ, Griffiths ID, Roberts DF. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989;36:178-82.
3. 3 Wordsworth P, Bell J. Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 1991;50:343-6.
4. 4 Cannon GW, Woods ML, Clayton F, Griffiths MM. Induction of arthritis in DA rats by incomplete Freund's adjuvant. J Rheumatol 1993;20:7-11.
5. 5 Lorentzen JC, Klareskog L. Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex. Scand J Immunol 1996;44:592-8.
6. 6 Lorentzen JC, Glaser A, Jakobsson L et al. Identification of rat susceptibility loci for adjuvant oil-induced arthritis. Proc Natl Acad Sci 1998;95:6383-7.
7. 7 Svelander L, Müssener Å, Erlandsson-Harris H, Kleinau S. Polyclonal Th1 cells transfer oil-induced arthritis. Immunology 1997; 91:260-5.
8. 8 Holmdahl R, Goldschmidt T, Kleinau S, Kvick C, Jonsson R. Arthritis induced in rats with adjuvant oil is a genetically restricted, αβ T-cell dependent autoimmune disease. Immunology 1992;76: 197-202.
9. 9 Jacobs ME, Steinberg AD, Gordon JK, Talal N. Adjuvant effects on poly I poly C in New Zealand mice. Arthritis Rheum 1972;15:201-7.
10. 10 Hilgers LAT, Snippe II. DDA as an immunological adjuvant. Research in Immunology 1992;143:494-503; discussion 574-6.
11. 11 Whitehouse MW, Orr KJ, Beck FWJ, Pearson CM. Freund's adjuvants: relationship of arthritogenicity and adjuvanticity in rats to vehicle composition. Immunology 1974;27:311-30.
12. 12 Domer JE, Stashak PW, Elkins K, Prescott B, Caldes G, Baker PJ. Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components. Cell Immunol 1986;101:403-14.
13. 13 Kumar P, Ahmad S. Glucan-induced immunity in mice against Plasmodium berghei. Ann Trop Med Parasitol 1985;29:211-13.
14. 14 Obaid KA, Ahmad S, Khan HM, Mahdi AA, Khanna R. Protective effect of L. donovani antigens using glucan as an adjuvant. Int J Immunopharmacol 1989;3:229-35.
15. 15 Alving CR. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunological adjuvants, Immunobiology 1993;187:430-46.
16. 16 Lemaire G, Tenu J-P, Petit J-P, Lederer E. Natural and synthetic trehalose diesters as immunomodulators. Med Res Rev 1986;6:243-74.
17. 17 Lorentzen JC, Klareskog L. Comparative susceptibility of DA, LEW, and LEW.1AV1 rats to arthritis induced with different arthritogens: mineral oil. Mycobacteria, muramyl dipeptide, avridine and rat collagen type II. Transpl Proc 1997;29:1692-3.
18. 18 Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Pristane-induced arthritis in rats. A new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996;149:1675-83.
19. 19 Niblack JF, Otterness IG, Hemsworth GR, Wolff III JS, Hoffman WW, Kraska AR. CP-20,961: A structurally novel, synthetic adjuvant. J Reticuloendothelial Soc 1979;26 (Suppl.):655-65.
20. 20 Chang YH, Pearson CM, Abe C. Adjuvant polyarthritis IV. Induction by a synthetic adjuvant: immunological, histopathological and other studies. Arthritis Rheum 1980;23:62-71.
21. 21 Pearson CM. Development of arthritis, periarthritis and periostis in rats given adjuvants. Proc Soc Exp Biol Med 1956;91:95-101.
22. 22 Ellouz F, Adam A, Ciorrubaru R, Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan subunits. Biochem Biophys Res Commun 1974;59:1317-25.
23. 23 Kohashi O, Aihara K, Ozawa A, Kotani S, Azuma I. New model of a synthetic adjuvant N-acetylmuramyl-L-alanyl-D-isoglutamine induced arthritis. Lab Inv 1982;47:27-36.
24. 24 Hedrich HJ. List of congenic and segregating inbred strains. In: Hedrich HJ, ed. Genetic Monitoring of Inbred Strains of Rats. New York: Gustav Fischer Verlag, 1990,481-6.
25. 25 Hünig T, Wallny HJ, Hartley JK, Lawtsky A, Tiefenthaler G. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J Exp Med 1989;169:73-86.
26. 26 Lorentzen JC, Erlandsson H, Müssener Å, Mattsson L, Kleinau S, Nyman U, Klareskog L. Specific and long-lasting protection from collagen-induced arthritis and oil-induced arthritis in DA rats by administration of immunogens. Scand J Immunol 1995;42:82-9.
27. 27 Sverdrup B, Klareskog L, Kleinau S. Common commercial cosmetic products induce arthritis in the DA rat. Environ Health Persp 1998;106:27-32.
28. 28 Potter M, Wax JS. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J Immunol 1981;32:1591-5.
29. 29 Janz S, Gawrisch K, Lester DS. Translocation and activation of protein kinase C by the plasma cell tumor-promoting alkane pristane. Cancer Res 1995;55:518-24.
30. 30 Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein [see comments]. Science 1990;249:1431-3.
31. 31 Ross GD, Cain JA, Myones BL, Newman SL, Lachmann PJ. Specificity of membrane complement receptor type Three (CR3) for β-glucans. Complement Inflammation 1987;4:61-74.
32. 32 Seljelid R. Tumour regression after treatment with animated β-1 -3D polyglucose is initiated by circulatory failure. Scand J Immunol 1989;29:181-92.
33. 33 Meacock SCR, Brandon DR, Billingham MEJ. Arthritis in Lewis rats induced by the non-immunogenic adjuvant CP20961: an immunohistochemical analysis of the developing disease. Ann Rheum Dis 1994;53:653-8.
34. 34 Vingsbo C, Jonsson R, Holmdahl R. Avridine-induced arthritis in rats; a T-cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 1995;99:359-63.